Xindong Shui
Key Laboratory Of Non Coding RNA And Drug Discovery
Chengdu, 610500, China
Chengdu, 610500, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Development of a Novel AAV-Mediated microRNA Gene Therapy for Spatial Suppression of BACE1 to Improve Cognitive Function in Alzheimer's Disease Model Mice.
Journal: Biomolecules
Published: June 18, 2026
Characteristics and clinical applicability of four dietary interventions for irritable bowel syndrome: A systematic review and meta-analysis.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: March 24, 2026
A Novel PROTAC Confers a Dual Benefit Against Amyloid and Tau Pathology in Alzheimer's Disease via DAPK1 Degradation.
Journal: International journal of biological sciences
Published: January 14, 2026
Selective degradation of DAPK1 via a novel hydrophobic tagging attenuates tau pathology in Alzheimer's disease.
Journal: Journal of advanced research
Published: August 09, 2025
Death-associated protein kinase 1-dependent SENP1 degradation increases tau SUMOylation and leads to cognitive dysfunction in a mouse model for tauopathy.
Journal: Molecular neurodegeneration
Published: June 23, 2025
Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: October 18, 2023
Quantitative Proteomic and Phosphoproteomic Analyses Reveal a Role of Death-Associated Protein Kinase 1 in Regulating Hippocampal Synapse.
Journal: Molecular neurobiology
Published: July 11, 2023
Activation of transient receptor potential vanilloid 1 ameliorates tau accumulation-induced synaptic damage and cognitive dysfunction via autophagy enhancement.
Journal: CNS neuroscience & therapeutics
Published: May 02, 2023
Death-associated protein kinase 1 phosphorylates MDM2 and inhibits its protein stability and function.
Journal: Archives of pharmacal research
Published: March 15, 2023
MiR-191-5p Attenuates Tau Phosphorylation, Aβ Generation, and Neuronal Cell Death by Regulating Death-Associated Protein Kinase 1.
Journal: ACS chemical neuroscience
Published: December 01, 2022
miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: May 31, 2022
Blocking ERK-DAPK1 Axis Attenuates Glutamate Excitotoxicity in Epilepsy.
Journal: International journal of molecular sciences
Published: April 12, 2022
Last Updated: 09/26/2026